Drimva

Merge Labs

Scientist - Non-Viral Gene Delivery

$120K–$215K

San Francisco Bay Area · On-site · Full-time · Posted Nov 4, 2026

Education
Ph.D. or equivalent experience in bioengineering, chemical engineering, drug delivery, neuroscience, molecular biology, or a related field.

About the job

Develops and evaluates non-viral gene delivery approaches for neural biosensors and actuators in preclinical models, supporting molecular brain-computer interface development and clinical translation.

What you'll do

  • Formulate, adapt, and characterize non-viral vehicles for nucleic acid delivery to the central nervous system; identify and secure access to promising technologies.
  • Design and interpret in vivo studies comparing delivery technologies, and develop assays to assess efficacy and tolerability.
  • Evaluate durability, repeat dosing, ultrasound-mediated blood-brain barrier opening, manufacturability, and cost; collaborate across scientific teams.

What they ask for

  • Ph.D. or equivalent experience leading research projects end-to-end in a related field.
  • Hands-on experience with non-viral delivery vehicles, including lipid or polymeric nanoparticles.
  • Expertise developing, optimizing, or evaluating gene delivery modalities.
  • Experience designing and executing in vivo studies and interpreting delivery and expression results.

Nice to have

  • Experience advancing a delivery technology through preclinical translation or into the clinic.
  • Experience sourcing or in-licensing delivery technologies, nanoparticle CMC or scale-up, repeat dosing, microfluidics, targeted nanoparticles, ultrasound delivery, or large animal models.

Pay

$120K – $215K (base salary)

Tools

lipid nanoparticles, polymeric nanoparticles, ultrasound-mediated blood-brain barrier opening, microfluidic formulation

AI focus

The role supports a brain-computer interface platform that integrates with advanced AI; it does not specify direct AI work.

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 6, 2026 (UTC)